Ischemic colitis can range from mild inflammation to life-threatening damage. Early diagnosis and tailored care make all the ...

Explore the complexities of Ulcerative Colitis, its causes, diagnostic methods, and breakthrough treatments for better management.

Johnson & Johnson announced new data from the Tremfya (guselkumab) phase 3 QUASAR long-term extension (LTE) study in adults with moderately-to-severely active ulcerative colitis (UC). These data are ...